A detailed history of Renasant Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Renasant Bank holds 7,776 shares of ABBV stock, worth $1.54 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
7,776
Previous 9,244 15.88%
Holding current value
$1.54 Million
Previous $1.68 Million 20.8%
% of portfolio
0.98%
Previous 1.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $227,231 - $265,355
-1,468 Reduced 15.88%
7,776 $1.33 Million
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $144,796 - $164,982
-906 Reduced 8.93%
9,244 $1.68 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $146,681 - $165,198
1,066 Added 11.73%
10,150 $1.57 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $135,460 - $156,815
1,014 Added 12.57%
9,084 $1.35 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $198,499 - $247,020
-1,498 Reduced 15.66%
8,070 $1.09 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $71,581 - $82,437
-495 Reduced 4.92%
9,568 $1.52 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $67,633 - $81,110
-489 Reduced 4.63%
10,063 $1.63 Million
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $192,591 - $220,889
1,435 Added 15.74%
10,552 $1.42 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $183,997 - $233,921
1,337 Added 17.19%
9,117 $1.4 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $232,416 - $288,363
1,761 Added 29.26%
7,780 $1.26 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $140,733 - $178,068
1,310 Added 27.82%
6,019 $815,000
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $43,730 - $49,640
-411 Reduced 8.03%
4,709 $508,000
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $4,208 - $4,688
40 Added 0.79%
5,120 $576,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $74,576 - $82,099
-729 Reduced 12.55%
5,080 $549,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $467,566 - $631,264
5,809 New
5,809 $622,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Renasant Bank Portfolio

Follow Renasant Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.